Rx risk communication meeting
FDA public meeting to seek input on the agency's risk communication mechanisms is slated for Dec. 7-8. Discussion topics include patient information sheets, health care professional sheets, talk papers, public health advisories, CDER's educational campaigns and website. The meeting will be held at the National Transportation Safety Board boardroom and conference center in Washington, D.C. (1"The Pink Sheet" Sept. 19, 2005, p. 18)...
You may also be interested in...
FDA will hold a public hearing on ways to better communicate information about drug risks and benefits, FDA Drug Safety Oversight Board Executive Director Susan Cummins said at the PDA/FDA Joint Regulatory Conference in Washington, D.C. on Sept. 13
The entry of India’s state-owned Indian Immunologicals and partner Griffith University in the COVID-19 vaccine race could potentially disrupt pricing dynamics. The alliance is developing a live-attenuated, single dose vaccine, which it hopes will be ready for launch in 18-24 months.
Shortly after wrapping up a Phase III trial for its proposed generic Advair Diskus product in the US, Cipla has won FDA approval for the first generic Proventil HFA product, as it continues to build up steam in the US respiratory market.